Journal of Gynecologic Oncology (JGO)

In this episode of the Journal of Gynecologic Oncology podcast, we explore a recent study by Nishimura and colleagues that examines the role of platinum-based chemotherapy in patients with intermediate-risk early-stage cervical cancer. The study identifies high-risk subgroups within the intermediate-risk population—those with multiple risk factors such as large tumor size, lymphovascular space inv...

In this episode of the Journal of Gynecologic Oncology podcast, we explore the findings of a recent study by Jamieson and colleagues on the use of circulating tumor DNA (ctDNA) in endometrial and ovarian cancer. We discuss how ctDNA could serve as a promising tool for real-time monitoring of tumor burden, treatment response, and early detection of recurrence. Tune in to learn how this minimally in...

In this episode of the Journal of Gynecologic Oncology podcast, we delve into a study examining the prognostic significance of HER2 expression in uterine carcinosarcoma (UCS), a rare and aggressive endometrial cancer. Conducted by Mizoguchi et al., the research analyzes HER2 status in 148 UCS patients using immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) testing. The findi...

In this episode of the Journal of Gynecologic Oncology podcast, we explore a recent study that evaluates the outcomes of risk-reducing salpingo-oophorectomy (RRSO) in asymptomatic women with germline homologous recombination repair (HRR) gene mutations. This research represents the largest cohort of asymptomatic Asian women undergoing RRSO, including carriers of BRCA1, BRCA2, and other HRR gene mu...

In this episode, we explore a translational study led by Sato and colleagues on the oral STAT3 inhibitor YHO-1701 and its efficacy in treating ovarian cancer. The study highlights YHO-1701's ability to inhibit tumor growth in various ovarian cancer cell lines and patient-derived cells, as well as its potential to reduce peritoneal metastasis in mouse models. By targeting the STAT3 pathway and...

In this episode, we explore a recent study led by Mayumi Kamata and colleagues from the Japanese Foundation for Cancer Research, investigating the effects of tumor spillage prevention in laparoscopic radical hysterectomy for early-stage cervical cancer. The study highlights the significant benefits of using preventive measures such as vaginal cuff formation or clip placement to prevent tumor spill...

In this episode, we delve into a pilot study exploring the relationship between chemotherapy-induced symptoms and circulating cytokine levels in ovarian cancer patients. Tang and colleagues used patient-reported outcomes (PROs) to measure symptom burden and analyzed cytokine fluctuations, such as IL-6 and TNF-α, during treatment. The study highlights how cytokine levels might influence common chem...

In this episode of the JGO Podcast, we explore a significant study comparing radical hysterectomy with primary chemoradiotherapy in patients with clinically early-stage cervical cancer and suspicious lymph nodes detected on imaging. The study, conducted by Olthof and colleagues in the Netherlands, examines recurrence-free and overall survival, treatment-related toxicity, and the implications of pr...

In this episode of the JGO Podcast, we delve into a pivotal study examining the therapeutic role of lymphadenectomy in patients with early-stage epithelial ovarian cancer. Conducted by Yang and colleagues, the study compares oncologic outcomes, including disease-free survival and overall survival, between patients who underwent lymphadenectomy and those who did not. The episode explores key findin...

In this episode of the JGO Podcast, we explore two Editor's Choice studies focused on ovarian cancer. First, we delve into the work of Nozaki and colleagues, who investigate the role of specific biomarkers in predicting patient responses to PARP inhibitors. Their findings challenge the conventional reliance on genomic instability scores alone and offer new insights into personalized treatment...

In this episode of the JGO Podcast, we delve into two Editor's Choice articles focused on endometrial cancer. First, we discuss the outcomes of the East Asia subgroup in the KEYNOTE-775 trial, exploring the efficacy and safety of lenvatinib plus pembrolizumab. Then, we introduce a study that analyzed the prognostic significance of immune subtypes in copy-number high endometrial cancer, highlig...

Welcome to the inaugural episode of the JGO Podcast! In this episode, we introduce the purpose and structure of our new weekly program, dedicated to providing concise and informative summaries of the latest research published in the Journal of Gynecologic Oncology. We explain what listeners can expect from each episode, including key highlights from selected articles, expert interviews, and more....